Geron | GERN - Net Income

Stock Price
1.77
Daily Change
0.02 1.14%
Monthly
9.26%
Yearly
38.28%
Q2 Forecast
1.61

Geron reported $-31.14M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Amgen USD 1.33B 1.88B Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Cassava Sciences USD -12.54M 1.73M Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Esperion Therapeutics USD 61.83M 93.16M Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Genmab DKK 31M 370M Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
MacroGenics USD -14.16M 30.98M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Novavax USD 17.53M 219.91M Dec/2025